- India started its COVID-19 vaccination drive on January 16
- It aims to inoculate 30 crore people by August
- Dr Paul urged the people not to doubt the efficacy of the vaccines
New Delhi: Covishield is safe and there is “no signal of concern” regarding it as of now, the Centre asserted on Wednesday (March 24) amid reports of possible side-effects of the Oxford-AstraZeneca’s COVID-19 vaccine and its suspension in some European countries. The AEFI (adverse event following immunization) committee which closely keeps track and records adverse events following immunisations has “concluded that thrombosis events due to Covishield in India is not a problem”.
Also Read: Now, Co-WIN Does Not Schedule Your Appointment For The Second Dose Of COVID-19 Vaccine
There is no signal whatsoever for this concern. Covishield is safe, please proceed with its scale-up and uptake. We want to assure that there is no risk of blood clotting-related complications that were suspected in some nations with Covishield, NITI Aayog member (Health) Dr V K Paul said in response to a query at a press conference.
ICMR Director General Dr Balram Bhargava said that both Covishield and Covaxin are effective against the UK and the Brazilian variants. He was asked if the vaccines that are being used right now in India are effective against the three new variants of concern — the UK variant, South African variant and the Brazilian variant.
It is well established by research studies in published literature that the vaccines available in our country — both Covishield and Covaxin — are effective against the UK and the Brazilian variants. The research work regarding the South African variant is ongoing at the moment, he added.
Dr Paul urged the people not to doubt the efficacy of the vaccines.
Please don’t spread doubt. As of today, these vaccines work on the good old virus as well as the new variants, he said.
He appealed to people to follow COVID-appropriate behaviour and use vaccination as a tool to battle this second peak.
Also Read: India’s Coronavirus Vaccination: People Above 45 Years Of Age To Get COVID-19 Vaccine From April 1
(Except for the headline, this story has not been edited by NDTV staff and is published from a syndicated feed.)
NDTV – Dettol Banega Swasth India campaign is an extension of the five-year-old Banega Swachh India initiative helmed by Campaign Ambassador Amitabh Bachchan. It aims to spread awareness about critical health issues facing the country. In wake of the current COVID-19 pandemic, the need for WASH (Water, Sanitation and Hygiene) is reaffirmed as handwashing is one of the ways to prevent Coronavirus infection and other diseases. The campaign highlights the importance of nutrition and healthcare for women and children to prevent maternal and child mortality, fight malnutrition, stunting, wasting, anaemia and disease prevention through vaccines. Importance of programmes like Public Distribution System (PDS), Mid-day Meal Scheme, POSHAN Abhiyan and the role of Aganwadis and ASHA workers are also covered. Only a Swachh or clean India where toilets are used and open defecation free (ODF) status achieved as part of the Swachh Bharat Abhiyan launched by Prime Minister Narendra Modi in 2014, can eradicate diseases like diahorrea and become a Swasth or healthy India. The campaign will continue to cover issues like air pollution, waste management, plastic ban, manual scavenging and sanitation workers and menstrual hygiene.